Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on September 14, 2026

18 hours ago

Evaxion applies its AI-Immunology™ platform in autoimmune diseases

Indeterminate GlobeNewswire

18 hours ago

Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models

Indeterminate GlobeNewswire

18 hours ago

Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management

Indeterminate GlobeNewswire

18 hours ago

Revelyx Bio Reports Positive Topline Phase 2 Results for YY003, a Recombinant, Ready-to-Use Liquid Botulinum Toxin Type A, in Moderate-to-Severe Glabellar Lines

Indeterminate GlobeNewswire

18 hours ago

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

Indeterminate GlobeNewswire

18 hours ago

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis

Indeterminate GlobeNewswire

18 hours ago

Leios Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for 10XB-101 for Moderate-to-Severe Submental Fat Fullness

Indeterminate GlobeNewswire

18 hours ago

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

Indeterminate GlobeNewswire

18 hours ago

Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study

Indeterminate GlobeNewswire

18 hours ago

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

Indeterminate GlobeNewswire

18 hours ago

Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program 

Indeterminate GlobeNewswire

Sep. 14, 2026

As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers

Indeterminate GlobeNewswire

Sep. 14, 2026

Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma

Indeterminate GlobeNewswire

Sep. 14, 2026

Slate Medicines Appoints Kenneth Koblan, PhD, as Chief Scientific Officer

Indeterminate GlobeNewswire

Sep. 14, 2026

Soleo Health Expands Atlanta Footprint With Infusion Centers In Woodstock and Fayetteville, Georgia

Indeterminate GlobeNewswire

Sep. 14, 2026

Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)

Indeterminate GlobeNewswire

Sep. 14, 2026

Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market

Indeterminate GlobeNewswire

Sep. 14, 2026

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 14, 2026

Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development

Indeterminate GlobeNewswire

Sep. 14, 2026

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

Indeterminate GlobeNewswire